dismiss

Come visit us at Booth 901 at AHRMM in Washington, DC
Mark your calendars! On August 2nd is our upcoming LIVE Clean Sweep Auction

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Send us your Comments

 

More Industry Headlines

Henry Ford Cancer Institute treats first patient with ViewRay's MRIdian Linac 'Takes off the blindfold' for radiation oncologists

Philips and West Physics partner on CT dose management program Deal aims at helping providers meet dose management needs

Taking the bite out of rabies In 1885 Louis Pasteur successfully tested his rabies vaccine

Research team develops surgical glue that's visible with CT, X-ray and ultrasound Viable alternative to surgical staples

Medic Vision receives U.S. patent for XR-29 Dose-Check system 'Fully expects' imaging service providers to respect its patent rights

GE Healthcare, Jefferson Health partner for $1 billion in efficiencies Eight-year deal will put over 100 GE staffers into 13 network hospitals

ECRI launches its ValuVu product evaluation workflow platform Designed for supply chain and value analysis professionals

PET scans could improve dementia diagnosis in two-thirds of patients 'A swift and accurate diagnosis has a huge impact on access to Alzheimer's treatments.'

Mayo launches new $1.5 billion integrated Epic EHR system Customized to 'specific needs of Mayo Clinic patients and staff'

Philips acquires ultrasound software company TomTec Third deal in the past thirty days

On the battlefield, a new technique to prevent infection

by Olga Deshchenko , DOTmed News Reporter
In the combat zones of Afghanistan and Iraq, soldiers often suffer shrapnel wounds and burns as a result of improvised explosive device blasts.

But other threats - bacteria, viruses and fungi - linger in the air and soil. Contact with the soldiers' broken skin can lead to debilitating and potentially life-threatening infections.

Story Continues Below Advertisement

YOUR POTENTIAL IS WAITING

You may have all the right pieces in place. But unless all your resources -human and technological - are working together in perfect harmony, you've only scratched the surface of your capabilities. Do you have the tools you need to reach it? Click here>>>



With the goal of developing a treatment that can be applied to soldiers' wounds at battle zones and hospitals to prevent infections, the U.S. Department of Defense allocated a $1.5 million grant to researchers at the University of Michigan and the NanoBio Corporation, the university announced Tuesday.

Researchers at the university's Michigan Nanotechnology Institute for Medicine and Biological Sciences and the Ann Arbor-based NanoBio Corp., a biopharmeceutical company, will use the money to study the effects of nanoemulsion-based therapies on curbing wound and burn infections in combat situations.

"A broadly effective nanoemulsion-based wound treatment that can be safely and easily applied at the time of injury, without causing pain or interfering with wound healing, would have great value to prevent infection, increase survival and enable more rapid healing of wounded United States military personnel," Dr. James R. Baker, the principal investigator for the grant, said in prepared remarks.

Nanoemulsions are made up of soybean oil, alcohol, water and surfactants emulsified into droplets 200 to 600 nanometers in diameter, according to the release. Research shows that nanoemulsions are effective in combating various bacteria and viruses.

The two research entities will develop 10 new nanoemulsion formulations against bacteria, fungi and spores in lab culture studies. The formulations will then be studied on animals for safety and effectiveness before moving on to human trials.

Nanoemulsions have shown promising results in other aspects of health care. The application of nanoemulsions for the treatment of cold sores is currently undergoing phase 3 clinical trials. Nanoemulsions have also been studied to treat cystic fibrosis infections and develop vaccines against influenza and bioterrorism agents.

The $1.5 million grant will be distributed to the University of Michigan and NanoBio Corp. over a three-year period.

Related:


Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED